The manufacturers of Amitiza (lubiprostone) recently announced some positive results of ongoing studies into the safety and effectiveness of the medication as a treatment for constipation predominant IBS (IBS-C) and chronic idiopathic constipation (CIC).
According to the Sucampo press release, data from several studies were pooled, resulting in the following findings about Amitiza:
It is always heartening to hear about safe, effective treatments for IBS. Let's hope the trend continues!
Related Reading:
Good Amitiza News originally appeared on About.com Irritable Bowel Syndrome on Friday, December 4th, 2009 at 05:12:18.
Permalink | Comment | Email this
View the full article
According to the Sucampo press release, data from several studies were pooled, resulting in the following findings about Amitiza:
- The medication was effective regardless of the age, gender or race of study participants
- Symptom relief was experienced up to year (the length of the clinical trials)
- The medication helped those whose symptoms did not respond to any prior treatment.
It is always heartening to hear about safe, effective treatments for IBS. Let's hope the trend continues!
Related Reading:
| | Twitter | Newsletter Signup | Forum | |
Good Amitiza News originally appeared on About.com Irritable Bowel Syndrome on Friday, December 4th, 2009 at 05:12:18.
Permalink | Comment | Email this
View the full article
